To the Editor: In their excellent review article on cutaneoussquamous-cell cancers (March 29 issue),1 Alam and Ratner mentionsunscreen use but not the prevention of these cancers in certainpopulations of patients at high risk. Among recipients of solid-organtransplants, the incidence of cutaneous squamous-cell carcinomamay be more than 100 times the incidence in the general population.2Moreover, as many as 6 percent of renal-allograft recipientswith skin cancer may die of metastases.
Prophylactic measures, including the daily use of topical tretinoin,enhance the number and function of dendritic cells within theskin, a change seen in association . . . [Full Text of this Article]
References
This article has been cited by other articles:
Euvrard, S., Kanitakis, J., Claudy, A.
(2003). Skin Cancers after Organ Transplantation. NEJM
348: 1681-1691
[Full Text]